๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

Intralesional BCG in the treatment of metastatic malignant melanoma

โœ Scribed by Michael J. Mastrangelo; Hector L. Sulit; Liisa (Melartin) Prehn; Richard S. Bornstein; John W. Yarbro; Richmond T. Prehn

Publisher
John Wiley and Sons
Year
1976
Tongue
English
Weight
742 KB
Volume
37
Category
Article
ISSN
0008-543X

No coin nor oath required. For personal study only.

๐Ÿ“œ SIMILAR VOLUMES

Prospective comparison of intralesional
Prospective comparison of intralesional and multipuncture BCG in recurrent intradermal melanoma
โœ L. Nathanson; D. Schoenfeld; W. Regelson; J. Colsky; A. Mittelman ๐Ÿ“‚ Article ๐Ÿ“… 1979 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 458 KB

Fifty-nine patients with metastatic melanoma predominantly localized in the skin were randomly assigned to treatment with BCG given either intralesionally (IL-BCG) or by multiple puncture vaccination at a nontumor bearing site in the skin (MPV-BCG). Half the patients with IL-BCG experienced moderate

Adjuvant treatment of malignant melanoma
Adjuvant treatment of malignant melanoma with DTIC + estracyt or BCG
โœ Dr. Constantine P. Karakousis; Lawrence J. Emrich ๐Ÿ“‚ Article ๐Ÿ“… 1987 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 338 KB

Eighty-two patients with invasive malignant melanoma and no distant metastases were prospectively randomized following their surgical treatment to 1) observation; 2) chemotherapy with Dacarbazine (DTIC) 200 mg/M2 I.V. daily X 5 every 4 weeks and Estracyt 15 mg/kg orally daily for 1 year; and 3) immu